InVivo Therapeutics Holdings Corporation

NVIV

HealthcareNASDAQUS

$0.3207

-$0.1673 (-34.28%)

NVIV

Analysis Workspace

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.

Consensus

Buy

3 buy / 0 hold

Quality

N/A

Price Target

N/A

Forward Revenue

$400.0K

Dec 2021

InVivo Therapeutics Holdings Corporation · Forecast overview

Model view

Forward Revenue

$400.0K

Dec 2021

Revenue range

Low: $400.0K

High: $400.0K · Annual

EPS avg

$0.00

Consensus

Analyst coverage

Analysts

Bars show expected revenue while the line tracks expected EPS.

Annual

1 periods

Period	Revenue avg	Revenue range	EBITDA	EPS avg	Analysts
Dec 2021	$400.0K	$400.0K - $400.0K	N/A	$0.00	1

Loading analysis workspace